Skip to search formSkip to main contentSkip to account menu

ICI 174864

Known as: ICI-174864 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1999
Highly Cited
1999
Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus
1996
1996
Modulation of humoral immune response by central administration of leucine-enkephalin: Effects of μ, δ and κ opioid receptor antagonists
1994
1994
Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat
1994
1994
Delta-opioid receptor agonists inhibit neuromuscular transmission in human colon.
1990
1990
Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues.
Highly Cited
1990
Highly Cited
1990
Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats
1990
1990
Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats
1989
1989
Activation of central μ-opioid receptors is involved in clonidine analgesia in rats
1986
1986
Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217.
The opioid peptide antagonist, ICI 174864 ([allyl]2-Tyr-alpha-amino-isobutyric acid (Aib)-Aib-Phe-Leu-OH), can produce analgesic… 
Highly Cited
1985
Highly Cited
1985
Studies in vivo with ICI 174864 and [ D-Pen2, D-Pen5 ]enkephalin
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)